Insulin may increase disease severity and mortality of COVID-19 through Na+/H+ exchanger in patients with type 1 and type 2 diabetes mellitus
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s40618-022-01951-y.pdf
Reference29 articles.
1. Yang Y, Cai Z, Zhang J (2021) Insulin treatment may increase adverse outcomes in patients with COVID-19 and diabetes: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 12:696087. https://doi.org/10.3389/fendo.2021.696087
2. Shestakova MV, Vikulova OK, Elfimova AR, Deviatkin AA, Dedov II, Mokrysheva NG (2022) Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: a nationwide retrospective cohort study of 235,248 patients in the Russian Federation. Front Endocrinol (Lausanne) 13:909874. https://doi.org/10.3389/fendo.2022.909874
3. Mustroph J, Hupf J, Hanses F, Evert K, Baier MJ, Evert M et al (2021) Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19. ESC Heart Fail 8:309–316. https://doi.org/10.1002/ehf2.13063
4. Cure MC, Cure E (2022) Prolonged NHE activation may be both cause and outcome of cytokine release syndrome in COVID-19. Curr Pharm Des 28:1815–1822. https://doi.org/10.2174/1381612828666220713121741
5. Kaloyianni M, Bourikas D, Koliakos G (2001) The effect of insulin on Na+-H+ antiport activity of obese and normal subjects erythrocytes. Cell Physiol Biochem 11:253–258. https://doi.org/10.1159/000047811
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic;Medicina;2023-10-11
2. Association between serum complement 1q and the associated factors of acute ischemic stroke in patients with type 2 diabetes;Human & Experimental Toxicology;2023-08-07
3. Dissecting the Interrelationship between COVID‐19 and Diabetes Mellitus;Advanced Biology;2023-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3